Biomedical Aspects of Drug Targeting

Vladimir P. Torchilin

ISBN 10: 1441953124 ISBN 13: 9781441953124
Published by Springer US, Springer US Dez 2010, 2010
New Taschenbuch

From buchversandmimpf2000, Emtmannsberg, BAYE, Germany Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

AbeBooks Seller since 23 January 2017

This specific item is no longer available.

About this Item

Description:

This item is printed on demand - Print on Demand Titel. Neuware -Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the 'magic bullet,' or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 528 pp. Englisch. Seller Inventory # 9781441953124

Report this item

Synopsis:

Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the "magic bullet," or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Biomedical Aspects of Drug Targeting
Publisher: Springer US, Springer US Dez 2010
Publication Date: 2010
Binding: Taschenbuch
Condition: Neu

Top Search Results from the AbeBooks Marketplace